Skip to main content
Top
Published in: Endocrine 3/2011

01-06-2011 | Original Article

Activation of skin renin–angiotensin system in diabetic rats

Authors: Shao yun Hao, Meng Ren, Chuan Yang, Diao zhu Lin, Li hong Chen, Ping Zhu, Hua Cheng, Li Yan

Published in: Endocrine | Issue 3/2011

Login to get access

Abstract

The renin–angiotensin system (RAS) is reportedly involved in chronic diabetic complications such as diabetic nephropathy, but changes of the RAS in diabetic skin remain unknown. The aim of this study was to investigate the expression of angiotensin (Ang) II and its type 1 (AT1) and type 2 (AT2) receptors in diabetic skin tissues, and explore the relationship between the local RAS and pathological changes of diabetic skin. Our results showed that thinning of epidermis, degeneration of collagen, fracture of dermal layer, and atrophy/disappearance of subcutaneous fat were observed in diabetic skin. The expression level of AngII was increased in diabetic skin tissues compared to that in controls. mRNA and protein expression of AT1 receptor were also increased while the level of AT2 receptor decreased; the relative expression of AT1 to AT2 receptors was approximately threefold higher in diabetes than in controls. Furthermore, in the culture medium of primary cultured fibroblasts from diabetic skin, the concentration of AngII was significantly higher than that of normal control. The mRNA and protein expression of AT1 receptor was also increased in fibroblasts of diabetic skin compared to controls, while the protein expression of AT2 receptor was decreased. Taken together, our results suggest that the local RAS system is activated in diabetic skin and AngII receptor is likely to mediate the pathological changes of diabetic skin.
Literature
1.
go back to reference M. de Gasparo, K.J. Catt, T. Inagami, J.W. Wright, T. Unger, International union of pharmacology. XXIII. The angiotensin II receptors. Pharmacol. Rev. 52, 415–472 (2000)PubMed M. de Gasparo, K.J. Catt, T. Inagami, J.W. Wright, T. Unger, International union of pharmacology. XXIII. The angiotensin II receptors. Pharmacol. Rev. 52, 415–472 (2000)PubMed
2.
go back to reference H. Takeda, Y. Katagata, Y. Hozumi, S. Kondo, Effects of angiotensin II receptor signaling during skin wound healing. Am. J. Pathol. 165, 1653–1662 (2004)PubMedCrossRef H. Takeda, Y. Katagata, Y. Hozumi, S. Kondo, Effects of angiotensin II receptor signaling during skin wound healing. Am. J. Pathol. 165, 1653–1662 (2004)PubMedCrossRef
4.
go back to reference K.E. Rodgers, N. Roda, J.E. Felix et al., Histological evaluation of the effects of angiotensin peptides on wound repair in diabetic mice. Exp. Dermatol. 12, 784–790 (2003)PubMedCrossRef K.E. Rodgers, N. Roda, J.E. Felix et al., Histological evaluation of the effects of angiotensin peptides on wound repair in diabetic mice. Exp. Dermatol. 12, 784–790 (2003)PubMedCrossRef
5.
go back to reference U.M. Steckelings, T. Wollschlager, J. Peters et al., Human skin: source of and target organ for angiotensin II. Exp. Dermatol. 13, 148–154 (2004)PubMedCrossRef U.M. Steckelings, T. Wollschlager, J. Peters et al., Human skin: source of and target organ for angiotensin II. Exp. Dermatol. 13, 148–154 (2004)PubMedCrossRef
6.
go back to reference I.V. Yosypiv, Renin-angiotensin system-growth factor cross-talk: a novel mechanism for ureteric bud morphogenesis. Pediatr. Nephrol. 24, 1113–1120 (2009)PubMedCrossRef I.V. Yosypiv, Renin-angiotensin system-growth factor cross-talk: a novel mechanism for ureteric bud morphogenesis. Pediatr. Nephrol. 24, 1113–1120 (2009)PubMedCrossRef
7.
go back to reference H. Takeda, S. Kondo, Immunohistochemical study of angiotensin receptors in normal human sweat glands and eccrine poroma. Br. J. Dermatol. 144, 1189–1192 (2001)PubMedCrossRef H. Takeda, S. Kondo, Immunohistochemical study of angiotensin receptors in normal human sweat glands and eccrine poroma. Br. J. Dermatol. 144, 1189–1192 (2001)PubMedCrossRef
8.
go back to reference H. Takeda, Y. Katagata, S. Kondo, Immunohistochemical study of angiotensin receptors in human anagen hair follicles and basal cell carcinoma. Br. J. Dermatol. 147, 276–280 (2002)PubMedCrossRef H. Takeda, Y. Katagata, S. Kondo, Immunohistochemical study of angiotensin receptors in human anagen hair follicles and basal cell carcinoma. Br. J. Dermatol. 147, 276–280 (2002)PubMedCrossRef
9.
go back to reference Hw Liu, B. Cheng, Xb Fu, The expression of angiotensin II receptors in human sweat glands, sebaceous gland and hair follicles. Chin. J. Aesthet. Med. 15, 629–631 (2006) Hw Liu, B. Cheng, Xb Fu, The expression of angiotensin II receptors in human sweat glands, sebaceous gland and hair follicles. Chin. J. Aesthet. Med. 15, 629–631 (2006)
10.
go back to reference T.H. Yoo, J.J. Li, J.J. Kim et al., Activation of the renin-angiotensin system within podocytes in diabetes. Kidney Int. 71, 1019–1027 (2007)PubMedCrossRef T.H. Yoo, J.J. Li, J.J. Kim et al., Activation of the renin-angiotensin system within podocytes in diabetes. Kidney Int. 71, 1019–1027 (2007)PubMedCrossRef
11.
go back to reference M.E. Cooper, The role of the renin-angiotensin-aldosterone system in diabetes and its vascular complications. Am. J. Hypertens. 17, 16S–20S (2004). (quiz A12-14)PubMedCrossRef M.E. Cooper, The role of the renin-angiotensin-aldosterone system in diabetes and its vascular complications. Am. J. Hypertens. 17, 16S–20S (2004). (quiz A12-14)PubMedCrossRef
12.
go back to reference S. Mezzano, A. Droguett, M.E. Burgos et al., Renin-angiotensin system activation and interstitial inflammation in human diabetic nephropathy. Kidney Int. 64, S64–S70 (2003)CrossRef S. Mezzano, A. Droguett, M.E. Burgos et al., Renin-angiotensin system activation and interstitial inflammation in human diabetic nephropathy. Kidney Int. 64, S64–S70 (2003)CrossRef
13.
go back to reference G. Giacchetti, L.A. Sechi, S. Rilli, R.M. Carey, The renin-angiotensin-aldosterone system, glucose metabolism and diabetes. Trends Endocrinol. Metab. 16, 120–126 (2005)PubMedCrossRef G. Giacchetti, L.A. Sechi, S. Rilli, R.M. Carey, The renin-angiotensin-aldosterone system, glucose metabolism and diabetes. Trends Endocrinol. Metab. 16, 120–126 (2005)PubMedCrossRef
14.
go back to reference D.B. Vidotti, D.E. Casarini, P.C. Cristovam et al., High glucose concentration stimulates intracellular renin activity and angiotensin II generation in rat mesangial cells. Am. J. Physiol. Renal. Physiol. 286, F1039–F1045 (2004)PubMedCrossRef D.B. Vidotti, D.E. Casarini, P.C. Cristovam et al., High glucose concentration stimulates intracellular renin activity and angiotensin II generation in rat mesangial cells. Am. J. Physiol. Renal. Physiol. 286, F1039–F1045 (2004)PubMedCrossRef
15.
go back to reference J.L. Wilkinson-Berka, Angiotensin and diabetic retinopathy. Int. J. Biochem. Cell Biol. 38, 752–765 (2006)PubMedCrossRef J.L. Wilkinson-Berka, Angiotensin and diabetic retinopathy. Int. J. Biochem. Cell Biol. 38, 752–765 (2006)PubMedCrossRef
16.
go back to reference T. Konoshita, S. Wakahara, S. Mizuno et al., Tissue gene expression of renin-angiotensin system in human type 2 diabetic nephropathy. Diabetes Care 29, 848–852 (2006)PubMedCrossRef T. Konoshita, S. Wakahara, S. Mizuno et al., Tissue gene expression of renin-angiotensin system in human type 2 diabetic nephropathy. Diabetes Care 29, 848–852 (2006)PubMedCrossRef
17.
go back to reference M. Abiko, K.E. Rodgers, J.D. Campeau, R.M. Nakamura, G.S. Dizerega, Alterations of angiotensin II receptor levels in sutured wounds in rat skin. J. Invest. Surg. 9, 447–453 (1996)PubMedCrossRef M. Abiko, K.E. Rodgers, J.D. Campeau, R.M. Nakamura, G.S. Dizerega, Alterations of angiotensin II receptor levels in sutured wounds in rat skin. J. Invest. Surg. 9, 447–453 (1996)PubMedCrossRef
18.
go back to reference L.J. Min, T.X. Cui, Y. Yahata et al., Regulation of collagen synthesis in mouse skin fibroblasts by distinct angiotensin II receptor subtypes. Endocrinology 145, 253–260 (2004)PubMedCrossRef L.J. Min, T.X. Cui, Y. Yahata et al., Regulation of collagen synthesis in mouse skin fibroblasts by distinct angiotensin II receptor subtypes. Endocrinology 145, 253–260 (2004)PubMedCrossRef
19.
go back to reference N. Yevdokimova, S. Podpryatov, The up-regulation of angiotensin II receptor type 1 and connective tissue growth factor are involved in high-glucose-induced fibronectin production by cultured human dermal fibroblasts. J. Dermatol. Sci. 47, 127–139 (2007)PubMedCrossRef N. Yevdokimova, S. Podpryatov, The up-regulation of angiotensin II receptor type 1 and connective tissue growth factor are involved in high-glucose-induced fibronectin production by cultured human dermal fibroblasts. J. Dermatol. Sci. 47, 127–139 (2007)PubMedCrossRef
20.
go back to reference Y. Yahata, Y. Shirakata, S. Tokumaru et al., A novel function of angiotensin II in skin wound healing. Induction of fibroblast and keratinocyte migration by angiotensin II via heparin-binding epidermal growth factor (EGF)-like growth factor-mediated EGF receptor transactivation. J. Biol. Chem. 281, 13209–13216 (2006)PubMedCrossRef Y. Yahata, Y. Shirakata, S. Tokumaru et al., A novel function of angiotensin II in skin wound healing. Induction of fibroblast and keratinocyte migration by angiotensin II via heparin-binding epidermal growth factor (EGF)-like growth factor-mediated EGF receptor transactivation. J. Biol. Chem. 281, 13209–13216 (2006)PubMedCrossRef
21.
go back to reference Y. Kawaguchi, K. Takagi, M. Hara et al., Angiotensin II in the lesional skin of systemic sclerosis patients contributes to tissue fibrosis via angiotensin II type 1 receptors. Arthritis Rheum. 50, 216–226 (2004)PubMedCrossRef Y. Kawaguchi, K. Takagi, M. Hara et al., Angiotensin II in the lesional skin of systemic sclerosis patients contributes to tissue fibrosis via angiotensin II type 1 receptors. Arthritis Rheum. 50, 216–226 (2004)PubMedCrossRef
23.
go back to reference Y. Suzuki, M. Ruiz-Ortega, O. Lorenzo et al., Inflammation and angiotensin II. Int. J. Biochem. Cell Biol. 35, 881–900 (2003)PubMedCrossRef Y. Suzuki, M. Ruiz-Ortega, O. Lorenzo et al., Inflammation and angiotensin II. Int. J. Biochem. Cell Biol. 35, 881–900 (2003)PubMedCrossRef
Metadata
Title
Activation of skin renin–angiotensin system in diabetic rats
Authors
Shao yun Hao
Meng Ren
Chuan Yang
Diao zhu Lin
Li hong Chen
Ping Zhu
Hua Cheng
Li Yan
Publication date
01-06-2011
Publisher
Springer US
Published in
Endocrine / Issue 3/2011
Print ISSN: 1355-008X
Electronic ISSN: 1559-0100
DOI
https://doi.org/10.1007/s12020-010-9428-z

Other articles of this Issue 3/2011

Endocrine 3/2011 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.